Freenome, Inc. - Common stock (FRNM)

10.77
+0.78 (7.81%)
NASDAQ· Last Trade: Jul 31st, 11:01 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close9.990
Open10.50
Bid10.61
Ask10.85
Day's Range10.50 - 10.93
52 Week Range9.970 - 14.26
Volume425,501
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume751,056

Chart

News & Press Releases

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening –
By Freenome, Inc. · Via GlobeNewswire · July 27, 2026